Cohen & Steers, Inc. CNS
68.34 USD -1.63 (-2.33%)
Regular-session close
68.34 0.00 0.00%
After hours · Nov 17, 4:00 PM ET
68.00 Day range 71.59
58.39 52-week range 86.56
- YTD
- +8.86%
- 1 year
- +14.51%
News
seekingalpha.com The Winners Inside SCHD - November 2026 The SCHD dividend ETF has extended its year-to-date lead over SPY to more than 20%, despite recent market volatility. October was SCHD's best month of 2026, with a nearly 10% gain; 43 holdings have…
prnewswire.com Cohen & Steers Announces Changes to Realty Indexes NEW YORK, Nov. 13, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Realty Majors Portfolio Index (RMP), Global Realty Majors Portfolio Index (GRM) and…
globenewswire.com Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day Detailed launch readiness for relutrigine and ulixacaltamide, with PDUFA target action dates of December 27, 2026 and January 29, 2027benzinga.com Cohen & Steers Real Estate Opportunities Fund Acquires West Street Shopping Center In Keene, New Hampshire; Terms Not Disclosed The acquisition was made through a joint venture with DLC, a vertically integrated owner and operator of open-air shopping centers.West Street Shopping Center aligns with Cohen & Steers' investment…
prnewswire.com Cohen & Steers and DLC Acquire West Street Shopping Center in Keene, New Hampshire NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Cohen & Steers (NYSE: CNS) announced today that the Cohen & Steers Real Estate Opportunities Fund (REOF) has acquired West Street Shopping Center, a…
prnewswire.com Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for October 2026 NEW YORK, Nov. 9, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $99.6 billion at October 31, 2026, an increase of $3.7 billion from…
gurufocus.com Neurogene Reports Third Quarter 2026 Financial Results and Highlights Recent Updates Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological
prnewswire.com Corero Network Security Accelerates International Growth with Strategic Investment in Regional Leadership and Partnerships New leadership appointments strengthen EMEA and APAC operations as Corero builds on commercial momentum and industry recognition. LONDON, Nov. 4, 2026 /PRNewswire/ -- Corero Network Security (AIM:…
seekingalpha.com Dividend Champion, Contender, And Challenger Highlights: Week November 1 A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies that changed their dividends. Companies with upcoming ex-dividend dates.
globenewswire.com Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting PRINCETON, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026…
prnewswire.com Cohen & Steers, Inc. Declares Quarterly Dividend NEW YORK, Oct. 29, 2026 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the fourth quarter of 2026 in the amount of $0.67 per share of common…
businesswire.com LG CNS and D-Wave Announce Strategic Relationship to Advance Quantum Optimization Adoption in South Korea SEOUL, South Korea & PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and…
prnewswire.com Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a) NEW YORK, Oct. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of…
prnewswire.com Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a) NEW YORK, Oct. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of…
prnewswire.com Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a) NEW YORK, Oct. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the…
prnewswire.com Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a) NEW YORK, Oct. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of…
prnewswire.com Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a) NEW YORK, Oct. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the…
gurufocus.com Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization HONG KONG, Oct 27, 2026 - (ACN Newswire) - Micot Pharma (HKEX: 2335) presented its in-house neuroprotective drug candidate MT200605 in an oral presentation at t
gurufocus.com BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026 [url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated inve
gurufocus.com ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026 ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology and Phase 2 Clinical Pipelines at BIO-Europe 2026PR NewswireSEOUL, South Ko
fool.com Cohen & Steers: 3 Key Takeaways for Long-Term Investors Cohen & Steers generated $1.6 billion in third-quarter net inflows. The institutional pipeline reached $1.9 billion.
